Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

83
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
63.54(c) 63.61(c) 64.52(c) 64.25(c) 66.07(c) Last
12 779 184 8 457 272 13 874 280 18 405 300 14 607 457 Volume
+2.01% +0.11% +1.43% -0.42% +2.83% Change
More quotes
Financials ($)
Sales 2015 23 347 M
EBIT 2015 8 893 M
Net income 2015 6 814 M
Debt 2015 12 901 M
Yield 2015 3,36%
Sales 2016 26 768 M
EBIT 2016 10 440 M
Net income 2016 7 224 M
Debt 2016 14 705 M
Yield 2016 3,80%
PER 2015 17,32
PER 2016 19,59
EV / Sales 2015 4,93x
EV / Sales 2016 4,37x
Capitalization 102 295 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
05/06 | 02:50pmPresentation
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
04/24DJABBVIE : Hepatitis C Drug Granted Priority Review
04/24DJMERCK : Hepatitis C Treatment Shows 95% Cure Rate -- Update
04/24DJABBVIE : Hepatitis C Drug Granted Priority FDA Review
04/24DJMERCK : Hepatitis C Treatment Shows 95% Cure Rate
04/24 ABBVIE : U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral..
04/23DJAbbVie Profit Rises on Broad Sales Growth -- Update
04/23 ABBVIE : raises outlook as Humira again delivers earnings beat
04/23DJAbbVie Profit Rises on Broad Sales Growth
More news
Sector news : Biopharmaceuticals
04:07a MERCK KGAA : Wins German Innovation Award with Liquid Crystals
01:01a GILEAD SCIENCES : Announces Results From Studies Evaluating Sofosbuvir-Based Reg..
04/24 AKORN : EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities C..
More sector news : Biopharmaceuticals
4-Traders Strategies on ABBVIE INC 
02/13A likely recovery
More Strategies
News from SeekingAlpha
08:10a Astra Deals Add To Ballooning Up-Front Payments
04/24 French biotech's B-vitamin beats placebo in Phase 3 MS study
04/24 No Hiding From Respirageddon For Boehringer
04/24 Merck's HCV combo shows cure rates of 60 - 100% in three genotypes
04/23 AbbVie's (ABBV) CEO Rick Gonzalez on Q1 2015 Results - Earnings Call Transcri..


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF